Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,238 | 5 | 46.7% |
| Food and Beverage | $14,472 | 858 | 44.4% |
| Travel and Lodging | $2,858 | 6 | 8.8% |
| Education | $39.52 | 2 | 0.1% |
| Gift | $12.99 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $18,223 | 14 | $0 (2024) |
| ABBVIE INC. | $3,163 | 222 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,718 | 162 | $0 (2024) |
| Janssen Biotech, Inc. | $1,275 | 72 | $0 (2024) |
| QOL Medical, LLC | $1,139 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $572.12 | 31 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $517.46 | 25 | $0 (2023) |
| Ardelyx, Inc. | $480.55 | 26 | $0 (2024) |
| Daiichi Sankyo Inc. | $412.88 | 23 | $0 (2024) |
| Allergan, Inc. | $391.09 | 39 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,078 | 153 | Stryker Corporation ($18,223) |
| 2023 | $2,712 | 146 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($565.06) |
| 2022 | $2,130 | 125 | ABBVIE INC. ($545.83) |
| 2021 | $2,059 | 126 | AbbVie Inc. ($669.70) |
| 2020 | $847.97 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($292.69) |
| 2019 | $1,004 | 70 | AbbVie, Inc. ($297.71) |
| 2018 | $1,374 | 104 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($308.50) |
| 2017 | $1,416 | 92 | Valeant Pharmaceuticals North America LLC ($235.73) |
All Payment Transactions
872 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Boston Scientific Corporation | Hydra Jagwire (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Hydra_ENDO | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Stryker Corporation | NEPTUNE (Device) | Consulting Fee | Cash or cash equivalent | $7,350.00 | General |
| Category: NEPTUNE | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $38.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $139.12 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $43.53 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Stryker Corporation | NEPTUNE (Device) | Travel and Lodging | Cash or cash equivalent | $173.61 | General |
| Category: SURGICAL | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2024 | Stryker Corporation | NEPTUNE (Device) | Travel and Lodging | Cash or cash equivalent | $1,806.04 | General |
| Category: SURGICAL | ||||||
| 10/29/2024 | Stryker Corporation | TRITON CANISTER SYSTEM (Device) | Food and Beverage | In-kind items and services | $89.91 | General |
| Category: INSTRUMENTS | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2024 | Stryker Corporation | NEPTUNE (Device) | Travel and Lodging | Cash or cash equivalent | $406.12 | General |
| Category: SURGICAL | ||||||
| 10/27/2024 | Stryker Corporation | NEPTUNE (Device) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEPTUNE | ||||||
| 10/26/2024 | Stryker Corporation | NEPTUNE (Device) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: NEPTUNE | ||||||
| 10/26/2024 | Stryker Corporation | NEPTUNE (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEPTUNE | ||||||
| 10/25/2024 | Stryker Corporation | NEPTUNE (Device) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: NEPTUNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 695 | 816 | $495,775 | $79,615 |
| 2022 | 6 | 765 | 870 | $546,650 | $80,644 |
| 2021 | 6 | 752 | 884 | $540,100 | $80,577 |
| 2020 | 7 | 731 | 845 | $537,950 | $75,773 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 299 | $37,375 | $18,815 | 50.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 143 | 144 | $158,400 | $17,822 | 11.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 166 | 175 | $131,250 | $16,439 | 12.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 88 | 91 | $86,450 | $12,293 | 14.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 48 | 48 | $60,000 | $8,286 | 13.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $9,000 | $3,506 | 39.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $13,300 | $2,454 | 18.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 158 | 167 | $183,700 | $18,907 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 288 | $36,000 | $17,775 | 49.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 171 | 182 | $136,500 | $15,781 | 11.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 107 | 112 | $106,400 | $14,036 | 13.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 56 | 57 | $71,250 | $9,324 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $12,800 | $4,822 | 37.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 174 | 182 | $200,200 | $20,024 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 219 | 316 | $39,550 | $19,866 | 50.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 189 | 208 | $156,000 | $19,097 | 12.2% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 70 | 75 | $71,250 | $9,589 | 13.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 47 | 50 | $62,500 | $7,961 | 12.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 53 | 53 | $10,600 | $4,040 | 38.1% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 161 | 168 | $184,800 | $18,663 | 10.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 167 | 184 | $138,000 | $16,578 | 12.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 193 | 280 | $35,000 | $14,277 | 40.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 69 | 70 | $87,500 | $11,638 | 13.3% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 69 | 71 | $67,450 | $8,525 | 12.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 60 | 60 | $12,000 | $3,895 | 32.5% |
About Dr. Judd Adelman, MD
Dr. Judd Adelman, MD is a Gastroenterology healthcare provider based in North Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912940131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judd Adelman, MD has received a total of $32,620 in payments from pharmaceutical and medical device companies, with $21,078 received in 2024. These payments were reported across 872 transactions from 44 companies. The most common payment nature is "Consulting Fee" ($15,238).
As a Medicare-enrolled provider, Adelman has provided services to 2,943 Medicare beneficiaries, totaling 3,415 services with total Medicare billing of $316,609. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location North Charleston, SC
- Active Since 06/14/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1912940131
Products in Payments
- NEPTUNE (Device) $18,133
- XIFAXAN (Drug) $1,659
- LINZESS (Drug) $744.36
- SUCRAID (Drug) $619.84
- STELARA (Biological) $618.03
- ZENPEP (Drug) $600.97
- TRULANCE (Drug) $562.52
- RINVOQ (Biological) $546.93
- Sucraid (Drug) $519.26
- IBSRELA (Drug) $480.55
- REMICADE (Biological) $448.58
- HUMIRA (Biological) $431.30
- CREON (Drug) $376.47
- Humira (Biological) $344.65
- Linzess (Drug) $338.79
- DIFICID (Drug) $328.52
- VIBERZI (Drug) $312.61
- INJECTAFER (Drug) $309.03
- ENTYVIO (Biological) $292.59
- Entyvio (Biological) $268.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in North Charleston
Gregory Goodear, Md, MD
Gastroenterology — Payments: $14,323
David Florez, Md, MD
Gastroenterology — Payments: $13,914
Todd Snyder, Md, MD
Gastroenterology — Payments: $11,174
Salvatore Moscatello, Do, DO
Gastroenterology — Payments: $3,182